Elixinol Wellness Limited (EXL.AX)
AUD 0.04
(-7.5%)
AUD 0.04
(-7.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 8.26 Million | 7.05 Million | 9.33 Million | 15.01 Million | 30.71 Million | 37.13 Million |
| Cost of Revenue | 10.07 Million | 10.32 Million | 15.59 Million | 24.59 Million | 31.45 Million | 17.17 Million |
| Gross Profit | -1.8 Million | -3.26 Million | -6.25 Million | -9.58 Million | -743 Thousand | 19.95 Million |
| Operating Expenses | 3.42 Million | 6.73 Million | 9.35 Million | 15.74 Million | 25.08 Million | 20.93 Million |
| Selling, General and Administrative Expenses | 7.98 Million | 6.73 Million | 9.35 Million | 15.74 Million | 25.08 Million | 18.17 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 472 Thousand | 2.5 Million | 522 Thousand | 88 Thousand | 734 Thousand |
| Cost and Expenses | 14.25 Million | 17.05 Million | 24.94 Million | 40.33 Million | 56.54 Million | 38.1 Million |
| Operating Income | -5.99 Million | -10 Million | -15.6 Million | -25.32 Million | -25.82 Million | -978 Thousand |
| Interest Expense | 101 Thousand | 71 Thousand | 92 Thousand | 49 Thousand | 133 Thousand | - |
| Income Tax Expense | 3000.00 | 2000.00 | -65 Thousand | 4.2 Million | -7.53 Million | 363 Thousand |
| Earnings before Tax | -7.5 Million | -10.56 Million | -17.09 Million | -99.2 Million | -86.42 Million | -497 Thousand |
| Net Income | -7.5 Million | -10.57 Million | -17.02 Million | -104.5 Million | -80.62 Million | -860 Thousand |
| Earnings Per Share Basic | -0.01 | -0.03 | -0.04 | -0.45 | -0.41 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.03 | -0.04 | -0.45 | -0.41 | -0.01 |
| Weighted Average Shares Outstanding | 608.67 Million | 406.38 Million | 404.76 Million | 230.68 Million | 196.99 Million | 131.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 608.67 Million | 406.38 Million | 404.76 Million | 230.68 Million | 196.99 Million | 131.3 Million |
| Gross Margin | -0.22 | -0.46 | -0.67 | -0.64 | -0.02 | 0.54 |
| EBIT Margin | -0.82 | -1.32 | -1.51 | -1.47 | -0.75 | -0.00 |
| Profit Margin | -0.91 | -1.50 | -1.82 | -6.96 | -2.62 | -0.02 |
| EBITDA | -6.8 Million | -9.28 Million | -15.5 Million | -23.35 Million | -83.49 Million | 1.08 Million |
| Earnings Before Tax Margin | -0.72 | -1.42 | -1.67 | -1.69 | -0.84 | -0.03 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 6.77 Million | 8.26 Million | 4.81 Million | 3.45 Million | 3.83 Million | 7.05 Million |
| Cost of Revenue | 4.35 Million | 10.07 Million | 5.48 Million | 4.58 Million | 4.4 Million | 10.32 Million |
| Gross Profit | 2.41 Million | -1.8 Million | -671 Thousand | -1.13 Million | -564 Thousand | -3.26 Million |
| Operating Expenses | 4.38 Million | 4.62 Million | 2.22 Million | 2.4 Million | 3.35 Million | 6.73 Million |
| Selling, General and Administrative Expenses | 4.38 Million | - | 2.22 Million | 2.4 Million | 3.35 Million | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 15 Thousand | - | - | - | 472 Thousand |
| Cost and Expenses | 8.73 Million | 14.7 Million | 7.71 Million | 6.99 Million | 7.75 Million | 17.05 Million |
| Operating Income | -1.96 Million | -6.43 Million | -2.89 Million | -3.53 Million | -3.91 Million | -10 Million |
| Interest Expense | 66 Thousand | 68 Thousand | 73 Thousand | 28 Thousand | 34 Thousand | 71 Thousand |
| Income Tax Expense | 1000.00 | 3000.00 | 1000.00 | 2000.00 | - | 2000.00 |
| Earnings before Tax | -2.75 Million | -7.5 Million | -4.11 Million | -3.39 Million | -3.44 Million | -10.56 Million |
| Net Income | -2.75 Million | -7.5 Million | -4.11 Million | -3.39 Million | -3.44 Million | -10.57 Million |
| Earnings Per Share Basic | -0.00 | - | -0.01 | -0.01 | -0.01 | - |
| Earnings Per Share Diluted | -0.00 | - | -0.01 | -0.01 | -0.01 | - |
| Weighted Average Shares Outstanding | 984.63 Million | 608.67 Million | 813.52 Million | 462.88 Million | 406.45 Million | 406.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 997.92 Million | 608.67 Million | 813.52 Million | 462.88 Million | 406.45 Million | 406.38 Million |
| Gross Margin | 0.36 | -0.22 | -0.14 | -0.33 | -0.15 | -0.46 |
| EBIT Margin | -0.35 | - | -0.53 | -0.95 | -0.95 | - |
| Profit Margin | -0.41 | -0.91 | -0.85 | -0.98 | -0.90 | -1.50 |
| EBITDA | -2.37 Million | - | -2.56 Million | -3.27 Million | -3.63 Million | - |
| Earnings Before Tax Margin | -0.29 | -0.78 | -0.60 | -1.02 | -1.02 | -1.42 |
TRAN
SKUE
KAFR
6841
DNA
I9V